BOSTON, MA
Allocation by class
Portfolio Concentration
Top 3 weight
68.5%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 18.77M
Full voting authority
18.77M
shares
Joint voting authority
0.00
shares
No voting authority
0.00
shares
Investment Discretion (by position count)
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
Bicara Therapeutics Inc.SOLE | Common Stock | 2.39M | SH | $47.58M 29.16% | 2.39M | 0.00 | 0.00 |
Nuvation Bio Inc.SOLE | Common Stock Class A | 8.08M | SH | $34.67M 21.25% | 8.08M | 0.00 | 0.00 |
BridgeBio Oncology Therapeutics Inc.SOLE | Common Stock | 3.29M | SH | $29.44M 18.05% | 3.29M | 0.00 | 0.00 |
Kestra Med Technologies LtdSOLE | Common Stock | 1.02M | SH | $20.37M 12.49% | 1.02M | 0.00 | 0.00 |
Beta Bionics Inc.SOLE | Common Stock | 1.32M | SH | $13.19M 8.08% | 1.32M | 0.00 | 0.00 |
enGene Holdings Inc.SOLE | Common Stock | 876.36K | SH | $5.97M 3.66% | 876.36K | 0.00 | 0.00 |
Alumis Inc.SOLE | Common Stock | 241.25K | SH | $5.31M 3.26% | 241.25K | 0.00 | 0.00 |
Sana Biotechnology, Inc.SOLE | Common Stock | 843.75K | SH | $2.43M 1.49% | 843.75K | 0.00 | 0.00 |
ImageneBio, Inc.SOLE | Common Stock | 455.36K | SH | $2.28M 1.40% | 455.36K | 0.00 | 0.00 |
Replimune GroupSOLE | Common Stock | 248.67K | SH | $1.91M 1.17% | 248.67K | 0.00 | 0.00 |